S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

TERN Terns Pharmaceuticals Inc

5.96

0.08 (1.36%)

Last Updated: 02:28:50

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals Inc News

Form 8-K - Current report
Tuesday 19 November 2024 (1 week ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
Tuesday 19 November 2024 (1 week ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates
Wednesday 13 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences
Thursday 7 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 25 October 2024 (1 month ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Tuesday 8 October 2024 (2 months ago) • GlobeNewswire Inc.

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Friday 13 September 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 12 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 12 September 2024 (3 months ago) • Edgar (US Regulatory)

More Terns Pharmaceuticals Inc News Articles

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

Societe Generale Effekten

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

Banca Aletti and C

PAR AL BAHIA PN

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions